Literature DB >> 7117279

Hepatobiliary imaging using Tc-pyridoxylideneglutamate in the diagnosis of obstructive jaundice.

D N Clarke, P F Sharp, P W Brunt, N A Mowat, G Dascombe, F W Smith.   

Abstract

In 77 of 114 consecutive patients with suspected hepatobiliary disease undergoing cholescintigraphy a firm clinical or operative diagnosis was possible. These patients were classified as normal, or as having extra-hepatic biliary obstruction (partial or complete) or hepatocellular disease. On a double-blind basis cholescintigraphy correctly interpreted 18 of 20 (90%) normal controls, 12 of 14 (86%) of those with partial obstruction, 16 of 16 (100%) of those with complete obstruction and 23 of 27 (85%) of those with hepatocellular disease giving an overall diagnostic accuracy of 69 of 77 (90%). There were no complications or toxic reactions. Ninety-three percent of patients with biliary obstruction (sensitivity) and 87% of those without biliary obstruction (specificity) were correctly diagnosed. Cholescintigraphy is a non-invasive, cheap and reliable investigation which can be used in the presence of icterus to discriminate between patients with and without extra-hepatic biliary obstruction. In contrast to grey scale ultrasonography the production and interpretation of scans are simple. Moreover cholescintigraphy adds a functional element to the investigation of liver disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7117279     DOI: 10.1007/bf00255656

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  14 in total

1.  Technetium 99m-pyridoxylideneglutamate: a new hepatobiliary radiopharmaceutical. I. Experimental aspects.

Authors:  R J Baker; J C Bellen; P M Ronai
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

2.  Biliary scanning with Tc-99m pyridoxylideneglutamate--the effect of food in normal subjects: concise communication.

Authors:  R J Baker; M A Marion
Journal:  J Nucl Med       Date:  1977-08       Impact factor: 10.057

3.  Primer on certain elements of medical decision making.

Authors:  B J McNeil; E Keller; S J Adelstein
Journal:  N Engl J Med       Date:  1975-07-31       Impact factor: 91.245

4.  A test for patency of the cystic duct in acute cholecystitis.

Authors:  E A Eikman; J L Cameron; M Colman; T K Natarajan; P Dugal; H N Wagner
Journal:  Ann Intern Med       Date:  1975-03       Impact factor: 25.391

5.  Diagnosis of hepatobiliary disease by 99mTc-HIDA cholescintigraphy.

Authors:  L Rosenthall; E A Shaffer; R Lisbona; P Pare
Journal:  Radiology       Date:  1978-02       Impact factor: 11.105

6.  Technetium-99m pyridoxylideneglutamate (P.G.) cholescintigraphy.

Authors:  R C Stadalnik; N M Matolo; A L Jansholt; K A Krohn; G L DeNardo; E F Wolfman
Journal:  Radiology       Date:  1976-12       Impact factor: 11.105

7.  Hepatobiliary imaging: a comparison of 99Tcm-dihydrothioctic acid and 99Tcm-pyridoxylidene glutamate in the non-jaundiced patient.

Authors:  R E Jenner; E R Howard; M B Clarke; J J Barrett
Journal:  Br J Radiol       Date:  1978-11       Impact factor: 3.039

8.  The role of biliary scanning in the investigation of the surgically jaundiced patient.

Authors:  J A Williams; R J Baker; J F Walsh; M A Marion
Journal:  Surg Gynecol Obstet       Date:  1977-04

9.  Hepatobiliary imaging: the use of 99Tcm-pyridoxylidene glutamate scanning in jaundiced adults and infants.

Authors:  R E Jenner; E R Howard; M B Clarke; J J Barrett
Journal:  Br J Radiol       Date:  1978-11       Impact factor: 3.039

Review 10.  Cholangiography in the jaundiced patient.

Authors:  E Elias
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.